What’s the connection, IYHO, between CRP-associated risk and trigylceride-associated risk?
At this instant in time I have no opinion - humble or otherwise -g-. There are a variety of markers of MI risk that I haven't really spent any time vetting. Homocystine, triglycerides, mpo, ... . At some point I may look into genisi's pointer because it's genisi - but generally speaking it takes a lot of effort to sort through all the self serving or massively underpowered or very poorly analyzed or ... data to figure out which are actually gold and which trash.